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Recovery of Endoscopy Services in the Era of COVID-19: Recommendations from an 
International Delphi Consensus
Abstract
Objective:
The COVID-19 pandemic has had a profound impact on provision of endoscopy services 
globally as staff and real estate were repurposed. As we begin to recover from the 
pandemic, there is a need for a cohesive international approach and guidance to resume 
endoscopy services safely to avoid unintended harm from diagnostic delays. We aimed to 
provide consensus recommendations that clinicians can use to facilitate the swift and safe 
resumption of endoscopy services.  
Design:
An evidence based literature review was carried out on the various strategies used globally 
to manage endoscopy during the COVID-19 pandemic and infection control practice. A 
modified Delphi process involving international endoscopy experts was used to agree on the 
consensus statements. A threshold of 80% agreement was used to establish consensus for 
each statement. 
Results
27 out of 30 statements achieved consensus after two rounds of voting by 34 experts. The 
statements were categorised as pre-endoscopy, during endoscopy and post-endoscopy 
addressing relevant areas of practice such as screening, personal protective equipment, 
appropriate environments for endoscopy and infection control precautions particularly in 
areas of high disease prevalence. Recommendations around testing of patients and 
healthcare workers, appropriate locations of donning and doffing areas as well as social 
distancing measures prior to endoscopy are unique and not addressed by any other 
guidelines.
Conclusions
This is the first international consensus using a modified Delphi method to produce a series 
of best practice recommendations to aid with the safe resumption of endoscopy services 
globally in the era of COVID-19.  
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Summary
1. What is already known about this subject?
 COVID-19 has had a huge impact on elective endoscopy services worldwide
with drastic reduction in procedures being undertaken.
 As the first wave of the pandemic begins to settle, there is an urgent need to
resume endoscopy safely and swiftly.
 Many major national societies have produced guidelines for endoscopy
during the peak of the pandemic but there is no cohesive approach to
guidance on resuming endoscopy.
2. What are the new findings?
 A comprehensive series of recommendations encompassing pre, during and
post endoscopy practices
 Recommendations tailored according to disease prevalence
 Recommendations around widespread testing of patients and healthcare
workers
 Personal protective equipment tailored according to disease prevalence and
type of procedure
3. How might it impact on clinical practice in the foreseeable future?
 Streamline endoscopy practices to encourage confidence amongst staff and
patients on safe practices that will minimise disease transmission
 Enable endoscopy units to reopen safely and gradually increase the volume
of procedures performed
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Introduction
The novel coronavirus SARS-CoV-2 is highly infectious and predominantly spread by droplets 
emitted from the upper respiratory tract. Endoscopy is an aerosol generating procedure 
(AGP) with the potential to spread infection, thereby placing both health care professionals 
(HCP) and patients at risk. This led most national societies to produce guidance on how to 
improve safety in endoscopy during the pandemic.1–4 One of the key recommendations 
common to all these guidelines was a drastic reduction in procedure volume to only urgent 
and life- saving procedures. This was deemed necessary to minimise the spread of infection 
and divert health care resources from endoscopy to the frontline. Consequently, elective 
endoscopy ceased on a global scale. The unintended consequence of this is a resultant delay 
in diagnosis and treatment of various benign and malignant gastrointestinal diseases. This 
calls for urgent resumption of endoscopy services.
While prompt resumption in a safe setting is paramount to mitigate unintended (non-viral) 
adverse health outcomes from the pandemic, informed scientific guidance on how to fully 
restart endoscopy services is lacking. The guidance that exists is ad-hoc and heavily 
influenced by local and personal perspectives resulting in confusion and lack of compliance. 
Thus, there is a need for a cohesive approach to avoid any adverse consequences to HCP 
and patients.
The aim of this project was to gather opinions from endoscopy leaders around the globe in 
order to develop universally accepted consensus statements to guide the recovery of 
endoscopy services in the post-pandemic era. 
Methods
A modified Delphi process was used to develop the consensus statements for recovery of 
endoscopy services post COVID-19 pandemic. The main steps in the process were the 
selection of the consensus group, systematic literature reviews to collate supporting 
evidence, development of statements and anonymous voting on the statements until 
consensus was achieved. 
Selection of Delphi voting group
The outcome of the Delphi process is dependent on the voting group. We therefore 
developed inclusion criterion. These included, individuals who have demonstrated 
leadership in endoscopy at an International level, managed large endoscopy departments, 
produced high impact publications in the field of endoscopy or COVID-19 and a track record 
of developing International guidelines. The consensus group members were expected to 
meet at least three out of four criteria. We selected prospective members from Asia, 
Europe, the Middle East, USA, Russia, Australia and Latin America to achieve global 
representation. 
Development of Statements
Two endoscopy experts working in Italy (AR) and United Kingdom (PB), reviewed the 
literature and developed the statements. Evidence was obtained by searching Medline 
databases using the keywords “COVID-19”, “SARS-CoV-2” and “Endoscopy” and reviewing 
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1) Strongly Agree
2) Agree
3) Neither agree nor disagree
4) Disagree
5) Strongly Disagree
At the end of first round, qualitative comments, suggestions and views were communicated 
by email from the consensus group to the Core group (AR, PB) only. Based on the comments 
received, the statements selected for the second round of voting were modified prior to this 
round of voting. 
All votes were received by an independent researcher who had no connection to any of the 
participants and collated this data for final analysis.  
Patient and public involvement was not sought for the development of this consensus 
statement document.
Results
There were 34 experts from 24 countries who formed the consensus group. Voting was 
commenced on 17th May 2020 and completed by 24th May 2020 (both rounds). A total of 30 
statements were proposed and voted on. 17 out of 30 statements achieved consensus (at 
least 80% agreement) in the first round. The 13 statements which did not achieve consensus 
were modified based on feedback leading to improvement in consensus rate to 27/30 
following the second round.
The statements included in the final consensus are as follows (Table 1):
Pre-Endoscopy
public health guidance from the World Health Organisation (WHO), Centers for Disease 
Control and Prevention (CDC). Three broad domains of Pre-Endoscopy, Endoscopy and Post-
endoscopy were used to categorise the statements, reflecting a typical patient journey 
through the service. Two independent researchers who were not involved in voting verified 
the construct validity of these statements. Statements took into account variability in global 
disease prevalence with high prevalence areas defined as areas with estimated disease 
prevalence rates of 2% or higher. This was chosen based on estimates from badly affected 
countries such as the UK and USA where prevalence ranged between 1-5%.5,6 Inherent 
weaknesses of prevalence estimates including testing methodology, the variance in testing 
strategy and reporting of the real scale of infection that could adjust the benchmark for 
high prevalence remain unfortunately unavoidable. 
The Delphi questionnaire was delivered using Google Forms (Google, California, US) as part 
of the G-Suite package https://www.google.co.uk/forms/about/. All participants in the 
consensus group received a secure link to the voting document via email and voted 
anonymously. Consensus for a statement was agreed if at least 80% of the respondents 
strongly agreed or agreed with that statement. The level of agreement was determined on a 
five-point scale as follows:
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Screening for Infection
1.All patients coming for endoscopy should have a clinical history taken to diagnose active
COVID-19 disease or contact with any infected person in the last 2 weeks
2. The absence of clinical symptoms does not exclude SARS-CoV-2 infection as
asymptomatic infections are not uncommon
3. All patients undergoing endoscopy should be tested for SARS-CoV-2 infection 24-72
hours prior to endoscopy in high prevalence regions
4. Patients who have tested negative for SARS-CoV-2 infection may still be infective
5. Early data on the accuracy of point of care tests for detection of active infection is
promising and these tests could be used to aid with risk stratification of patients prior to
endoscopy in high prevalence regions
6.In the absence of universal testing, all patients having therapeutic endoscopic
procedures lasting longer than 1 hour should be tested for SARS-CoV-2 infection in high
prevalence regions
Multiple international society guidelines advocate the use of a screening questionnaire to 
risk stratify patients.1,2,4,7,8 Patients should be screened within 72 hours of their planned 
procedure and on the day of attendance. A positive screen should prompt the healthcare 
provider to consider deferring endoscopy if it is not urgent. 
However, asymptomatic SARS-CoV-2 infections are a recognised source for 
transmission.9,10,11,12 Viral loads detected in asymptomatic patients may be similar to that of 
symptomatic patients indicating that infection may be transmitted from asymptomatic 
individuals.13 Studies on the temporal dynamics of viral shedding and transmissibility of 
COVID-19 noted that the highest viral load was present at the time of symptom onset which 
may indicate that the peak of infectiousness could be on or just before symptom onset.14,15 
In view of the estimated proportion of asymptomatic patients (between 5-80%)16, symptom 
based screening alone will not be sufficient. Universal testing pre-procedure will guide risk 
stratification and level of precautions necessary. In a recent study from China,17 all patients 
completed screening questionnaires and RT-PCR tests 3 days prior to endoscopy. There 
were no cases of endoscopy related nosocomial COVID-19 disease transmission seen in a 
total of 1361 cases.
Sensitivity of conventional RT-PCR test is reported to be around 70% raising a concern about 
the value of these tests.18 False negatives are related to improper sampling techniques, low 
viral load, mutation of the viral genome and local prevalence. A modelling exercise reported 
that even in a higher prevalence population (2%) there would only be 10 false negative 
results per 10,000 individuals when using a test with a sensitivity of 95%.19 As disease 
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>95%.21 Data is limited but if results can be reproduced and tests become widely available,
then they could be adopted into routine practice.
If universal testing is not possible, focused testing of patients undergoing prolonged 
procedures should be considered given the link between exposure duration (> 15 minutes) 
and increased risk of viral transmission to HCP.22 Complex prolonged procedures should only 
be undertaken by highly experienced operators in high volume centres to minimise the risk 
of complications. Such centres should have a standard operating procedure for 
management of complications including the need for surgical backup. Knowledge of the 
SARS-CoV-2 status of these patients will allow streamlined management into COVID 
minimised pathways should emergency surgery or unplanned hospital admission be 
required.  
Protecting the Workforce
7. All HCPs should be self reporting any new symptoms to a responsible health
professional who is able to advise on further appropriate action
8. All HCPs working in endoscopy should be tested once for SARS-CoV-2 infection, undergo
daily symptom and temperature checks and in high prevalence regions consider retesting
on a regular basis
9. All patients attending for endoscopic procedures should wear simple surgical masks at
all times apart from the time when an endoscope has to be inserted into the oral cavity
10. All healthcare professionals should be wearing surgical masks at all times in clinical
areas within the endoscopy department
11. Elective endoscopy for suspected or confirmed COVID-19 patients should be deferred
until they are asymptomatic and have tested negative
prevalence declines, the false negative rate becomes less significant. 
Conventional RT-PCR testing may have its drawbacks. Although it only takes 4 hours to 
process the test, additional time is required for sample collection, transportation to the lab 
and interpretation of results followed by communication of results to the patient or HCP. 
This means that the tests have to be scheduled at least 48-72 hours in advance. Simple, 
rapid (<1 hour) tests performed at the point of care (POC) are a very desirable option as it 
can simplify the management of patients. 
POC tests can fall under two broad categories: those that detect active infection (molecular 
or antigen based) vs those detecting immune response (antibody) to a recent infection. The 
clinical significance of antibody tests is still not clear as the host immune response to recent 
SARS-CoV-2 varies and the relevance and duration of this response is also not well 
understood. POC tests that detect active infection will allow rapid identification of infection. 
The US FDA has recently approved a new test, Xpert Xpress SARS-CoV-2 (NAATs) with 
sensitivity of 95% that can provide results in less than 45 minutes.20 Clustered Regularly 
Interspaced Short Palindromic Repeat (CRISPR) based assays can be done by using a 
nasopharyngeal swab and can deliver results in 60 mins with reported sensitivity rate of 
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12. Patients should observe adequate social distancing for 1 week prior to endoscopy in
high prevalence regions to minimise the risk of viral exposure to health care professionals
in endoscopy departments
13. Health care professionals should receive appropriate training in infection control
practices and handling of personal protective equipment (PPE)
As we emerge from the pandemic, the areas where the virus is likely to linger will be in care 
homes and health care facilities. Given the heterogeneity of the symptom profile in COVID-
19,10 it may not be immediately obvious that certain symptoms (ageusia, anosmia) could 
represent infection. Therefore, strict guidance is required for all HCP to report any new 
symptoms. In the context of asymptomatic transmission, 23 clinical history alone is 
insufficient. The value of antibody-based tests is not yet clear, so it is advisable to test HCP 
for the presence of active infection using molecular tests until the reliability and relevance 
of antibody testing becomes apparent. In areas of high infection prevalence, regular testing 
may be useful until such time that a definitive, reliable vaccine becomes available or the 
significance of antibodies and level of immunity conferred is clear. There are no large scale 
robust studies on cyclical testing of healthcare workers. However, retesting on a fortnightly 
basis will enable detection of infection, allowing for the incubation period of 5-12 days.32 
Testing intervals will need to take into consideration testing resources and willingness of 
healthcare workers to comply with the recommendation. 
Surgical masks are an effective physical intervention to reduce the spread of respiratory 
viruses.24 They may not be very effective in preventing the wearer contracting infection but 
can reduce the spread of infection from the wearer particularly when social distancing may 
be difficult to implement in endoscopy departments.25 
The use of facemasks by patients is recommended in several endoscopy guidelines.26,2,1 
For endoscopies involving the oral route, the surgical mask will need to be removed just 
before the endoscope is inserted and replaced as soon as the patient has recovered enough 
to maintain oxygen saturation above 90% on room air.27 
Endoscopy can result in aerosolization of secretions containing virus. These contaminants 
can spread in the immediate environment28 and stay on hard surfaces for up to 3 days.29 
Therefore, it is vital that HCP should wear surgical masks in the endoscopy department at all 
times to protect themselves and patients. In addition to surgical masks or physical barriers 
(eye protection), strict adherence to hand hygiene including handwashing or use of alcohol 
gels are required and should form a crucial part of infection control practice on the 
endoscopy unit. 
Emergency procedures for potentially life threatening conditions should not be deferred 
and the risks of COVID-19 transmission should be mitigated by effective measures. All 
international society guidance were consistent in recommending postponement of elective 
endoscopy in COVID-19 patients.30 Viral shedding can occur even after the patient has 
stopped displaying symptoms.31 The link between PCR positivity for viral RNA, viable viral 
shedding, viral load and risk of viral transmission is not clear and therefore the safest 
strategy seems to be postponing the procedure.
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14. Gastroscopy is an aerosol generating procedure (AGP) and health care professionals
should wear enhanced PPE (N95/FFP3 respirators) in high prevalence regions
15. In high prevalence regions, the use of enhanced PPE (N95/FFP3 respirators) for both
upper and lower gastrointestinal endoscopic procedures is recommended due to
uncertainty surrounding the risk of infection during colonoscopy
16. In low prevalence regions, standard PPE (surgical mask) is sufficient for low aerosol
generating procedures such as colonoscopy
17. In the absence of active testing all patients undergoing endoscopic procedures should
be presumed to be potentially infective and health care professionals should wear
enhanced PPE (N95/FFP3 respirators)
Standard PPE encompasses a single pair of gloves, hairnet, protective eyewear (goggles or 
face shield), long sleeved fluid resistant gowns, shoe covers, and a simple surgical mask. 
Enhanced PPE includes all the above except the single gloves, which get replaced by double 
gloves and the surgical mask which gets replaced by an FFP-3 (N-95) respirator. Surgical 
masks are designed to block large particles but are less effective in blocking smaller particle 
aerosols (<5 μm). However, N-95 respirator masks filter at least 95% of aerosols (<5 μm).35 
Several studies have shown surgical masks to be non-inferior to N-95 respirators in the 
prevention of viral infections like influenza. 36,37 Notably, none of these trials were 
performed with SARS-CoV-2 virus or in the context of AGP.
On the other hand, a systematic review and a meta-analysis involving AGP, showed a 
benefit in using N95 respirators over standard masks in protecting HCP from SARS although 
the data was imprecise with wide confidence intervals.38 There is limited evidence that air 
powered respirator hoods may provide greater protection than N95/FFP3 respirators which 
depend on the mask being adequately fitted to the face for maximum protection.39,40 
However, there are no comparative trials. Users do not need to be fit tested for loose fitting 
respirator hoods and these may be more useful for high aerosol generating procedures. 
Social distancing for 1 week prior to endoscopy may protect against exposure to the virus 
particularly in areas of high prevalence. The median incubation period for SARS-CoV-2 is 
approximately 5 days32 which justifies a 7 day period  of social distancing. In regions where 
prompt testing cannot be carried out then a combination of symptom based screening and 
social distancing for a week prior to endoscopy is the next best approach. 
HCP working in endoscopy are at a higher risk of contracting the virus.33 These risks should 
be mitigated by ensuring adequate supply of PPE and the correct technique of wearing 
(donning) and removing (doffing) PPE to avoid inadvertent contact with the face. A buddy 
system may also be useful where another colleague assists in “donning” and “doffing” to 
ensure compliance.34 HCP should also be trained in correct hand hygiene practices. 
During Endoscopy
Personal Protective Equipment (PPE) 
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Currently, colonoscopy is not universally classified as an AGP but the risk of aerosolisation 
increases with overdistension of the colon and exchange of devices through the accessory 
channel of the colonoscope. A recent study from COVID-19 patients demonstrated the 
inability to isolate infective virons from their stool despite an abundance of viral RNA in the 
stools.41 However, the risk of gut colonisation and faeco-oral transmission does exist given 
the presence of key ACE2 and transmembrane serine protease 2 receptors required for 
SARS-CoV-2 entry that are present in the oesophagus, ileum and colon.42 These 
uncertainties related to the risk associated with colonoscopy resulted in differing 
recommendations between high and low prevalence regions. 
The availability of testing, cost and time taken to obtain results can be a significant issue in 
some parts of the world. Given the risk of asymptomatic infection, the safest approach in 
the absence of testing would be to wear enhanced PPE during AGP. If patients are screened 
and tested negative for infection in low prevalence areas, it would be reasonable to wear 
standard PPE for upper GI endoscopy. 
Environment 
18. The “Donning” area should be located outside of the endoscopy room and away from 
the “doffing” area
Viral respiratory infections can be spread by touching an infected person or the surfaces and 
fomites that the person has either touched, or on which virus-containing droplets expired 
by the person have landed. Therefore, frequent hand-washing and maintaining a distance of 
at least 1m are considered the main precautions against contracting the infection.43 Another 
notable transmission route is via aerosol. Immediately after droplets are expired, the liquid 
content starts to evaporate, and some droplets become so small that transport by air 
current affects them more than gravitation. They can carry their viral content meters away 
from where they originated. The sequence and place of donning is important to avoid self 
infection and PPE contamination. 
19. All patients in high prevalence regions should change into hospital gowns before 
entering the endoscopy suites
During endoscopy, there is a risk of exposure to aerosols, splashes of body fluids and 
inadvertent contact with patients and HCP where cloth contamination may occur. Chin et 
al., showed that SARS-CoV-2 virus remains stable on fabric for up to 2 days.44 Contaminated 
clothes can become potential sources of spreading infection in the community. 
20. All patients with suspected or confirmed COVID-19 infection should be endoscoped in 
negative pressure rooms. In the absence of a negative pressure room, endoscopy 
departments should have a designated room and /or specific slots for these patients
The one-way flow of air with no leakage of infected aerosol into the environment is a key 
advantage of a negative pressure room which could reduce the risk of infection 
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transmission.45 However, providing a negative pressure room may not always be possible. 
Therefore, a specific room should be allocated for high risk patients so as to minimise the 
risk to uninfected patients. If this is not practical, then a specific slot should be allocated 
ideally at the end of a morning or afternoon session to allow for terminal cleaning. Spacing 
of procedures in the absence of a negative pressure environment was not agreed in this 
consensus as explored in the discussion. 
POST-ENDOSCOPY
Statement 21
The “Doffing” area for removal of PPE could be appropriately positioned in one corner of 
the room
Accidental contamination during the act of removal of PPE is possible. Due to the distance 
that large droplets can travel, a 2 metre distance between the doffing station and potential 
source of infection is recommended.46 The biggest risk of inadequate doffing will be to 
nullify the protection conferred by PPE to HCP. The sequence and technique of doffing are 
as important as the distance from the procedure spot. 
Statement 22
The endoscopy procedure room should be deep cleaned after every procedure in a 
suspected or confirmed case of COVID-19 
CDC  guidance47 on disinfection of medical equipment advises the use of bleach containing 
solutions in a ratio of 1:100 as these agents are effective viricidals. ASGE guidelines advise 
terminal cleaning after known cases of transmissible infection by organisms as determined 
by the local institution.48 The terminal cleaning process should involve cleaning the room 
and all surfaces to remove soil and biofilm followed by appropriate disinfection. 
Statement 23
Patients with suspected or confirmed COVID-19 infection should be recovered in a 
designated area away from all the other non-COVID-19 patients
WHO guidance for rational use of PPE states that patients with COVID-19 should be 
cohorted to streamline workflow.43 BSG guidance recommends linear flow through the 
endoscopy unit with separate entrances and exits for patients with suspected or confirmed 
COVID-19 infection.1 There should be a designated recovery area for patients suspected of 
COVID-19 with separate staff in appropriate PPE. If there are space constraints, then known 
COVID-19 patients should be scheduled at the end of the day when all other patients from 
recovery have been discharged to minimise contact with non-infected patients.
Statement 24
In high prevalence regions, health care professionals in the endoscopy recovery areas (for 
non COVID-19 patients) should wear standard PPE with surgical masks
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Close contact with the patient may be unavoidable due to the need to monitor vital signs or 
conduct clinical examination as required if the patient is symptomatic. Passage of 
gastrointestinal contents is not uncommon following endoscopy and this can result in 
spread of infection. Direct clinical care should therefore be provided to patients in the 
recovery area using standard PPE (surgical mask, gown, gloves, eye protection). 
Statement 25
Strict adherence to endoscope disinfection policies are mandatory
The SARS-CoV-2 virus is sensitive to the standard endoscope cleansing measures and no 
new measures are required.7 The standards applied should be consistent with the 
recommendations set out by international endoscopy guidelines.48,49 If current guidelines 
are followed, the risk of viral transmission secondary to endoscope disinfection practice is 
extremely unlikely. 
Statement 26
Adequate social distancing should be maintained throughout all areas of the endoscopy 
unit in high prevalence regions
Social distancing is an important means of minimising nosocomial spread.50 Endoscopy is a 
team based activity where multiple HCP come into contact with patients and relatives. 
Adequate social distancing should be practiced with a 1-2m distance between staff and 
patients whenever possible. Reception, waiting areas, recovery space may all need to be 
redesigned to limit the number of people in a confined zone. The use of protective screens 
in reception and separate recovery area for suspected or confirmed COVID-19 patients 
should be considered. A no visiting policy (except if deemed absolutely necessary) should be 
enforced.27 Accompanying persons should drop the patient off at the entrance to the 
endoscopy unit and wait off premises until the patient is ready to be collected. They too 
should adhere to social distancing measures and wear face coverings at all times.  
Statement 27
All patients should be followed up by phone in 10-14 days to identify any symptoms 
suggestive of COVID-19 in high prevalence regions 
There remains a risk that patients may be exposed to SARS-CoV-2 when attending for their 
endoscopic procedures. The median incubation period of the virus is 5 days and the vast 
majority who do develop symptoms will do so within 11.5 days.32 
Most National Guidance on endoscopy currently advocates contacting patients within 14 
days34 to enquire about symptoms suggestive of COVID-19. 
Discussion
A recent study looked at the impact of a hypothetical suspension of elective endoscopy for 6 
months in USA, and predicted a delayed diagnosis of over 2,800 colorectal cancers and 
22,000 high-grade adenomatous polyps with malignant potential.51 The 6 month mortality 
rate for those eventually diagnosed with colorectal cancer would increase by 6.5%.52 This 
emphasises the need for a rapid yet safe resumption of endoscopy services and our 
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consensus guidance aims to facilitate that. 
This is the first international consensus document produced using a modified Delphi process 
to enable a cohesive approach to resuming endoscopy services globally. Although various 
national societies have produced separate guidelines for endoscopy practice during this 
pandemic, we are now in a post-pandemic phase where infection prevalence is rapidly 
declining. We have therefore accounted for prevalence in our statements and have 
comprehensively mapped the entire patient journey through endoscopy and risks 
associated with it for patients and HCP.
Table 2 summarises our recommendations and draws comparison with other published 
major guidance. Importantly, we identify key recommendations below that have evolved 
through this Delphi consensus that set it apart from other guidelines. 
The value of testing during the post-pandemic phase should not be underestimated and this 
was demonstrated by strong consensus around pre-procedure testing of all patients in high 
prevalence regions. This will allow services and patients to be risk stratified with increased 
confidence in ramping up the volume of endoscopy with reasonable use of PPE. We also 
highlight high sensitivity point of care testing as a way of minimising risks of false negative 
tests. Concerns related to false negative rates of current molecular tests have been 
eloquently highlighted in a recent publication predicting that in an endoscopy unit that 
serves 10,000 patients annually in the United States (prevalence: 0.26%), a POC test with 
95% sensitivity would result in only 1 false negative result. Comparatively, in a higher-
prevalence population of 2%, there would be 10 false negative results per 10,000 patients.19  
This is no higher than a fatal automobile crash in the USA (mortality of 10.3 per 100,000 
according to CDC figures). 
The is the first document recommending testing of all patients having an endoscopy longer 
than an hour, highlighting the increased risk of infection with prolonged aerosol generation. 
Testing of HCP has also emerged as another important recommendation given that HCP are 
increasingly recognised as a nidus for future clusters of outbreaks in hospital. 
The practice of social distancing for a week pre-endoscopy prompted much debate prior to 
achieving consensus. In the current climate, without the realistic prospect of a vaccine or 
treatment, social distancing will remain an integral part of reducing transmission risk. We 
recognise that isolating from household members is not required at present but distancing 
from external contacts is essential. This approach will strike a balance between protecting 
patients and staff from infection without negatively affecting uptake of endoscopy. Indeed, 
there is strong data from a recent meta-analysis demonstrating the effect of non-
pharmacological interventions such as physical distancing, face masks and eye protection on 
preventing transmission of SARS-CoV-2 in healthcare and community settings.53     
We have also produced a set of unique recommendations providing practical advice around 
the location of “donning” and “doffing” areas not covered by other endoscopy guidelines. 
We failed to achieve consensus around the use of general anaesthesia with endotracheal 
intubation for upper endoscopic procedures longer than 30 minutes. Long procedures are 
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less likely to be well tolerated thereby increasing the risk of coughing and aerosol 
generation. General anaesthesia may reduce this risk by eliminating coughing. However, 
endotracheal intubation is in itself an AGP and there was concern that this would simply be 
transferring the risk from the endoscopist to the anaesthesiologist. We believe that the 
decision regarding the use of anaesthesia will be based on the complexity and duration of 
procedures and availability of anaesthesia rather than on the risk of infection. 
The other statement that lacked sufficient agreement was on the use of single use 
accessories in areas of high disease prevalence. The fact that the virus can easily be killed 
during routine disinfection procedures with ethanol, glutaraldehyde and sodium 
hypochlorite54 swayed opinions. We believe that single use accessories will become a 
universal standard once readily affordable and available. 
Another recommendation that failed to achieve consensus was on implementing downtime 
of 20 to 30 minutes after each procedure. SARS-CoV-2 infection is transmitted by droplets 
and these droplets can remain suspended for variable length of time depending on size and 
air exchange rates, before settling.55 These issues have led to recommendations on a 30-60 
mins delay between procedures if the procedure was carried out in the absence of a 
negative pressure setting.27 However, the uncertainties around the air exchange rates and 
differences in aerosols related to gastroscopy and colonoscopy did not allow for a 
consensus to be reached on exact length of time and type of procedure.
In the absence of high quality data, we have produced a series of best practice 
recommendations around the patient’s journey through endoscopy. These practical 
recommendations can empower units around the world to ensure a safe and rapid 
resumption of endoscopy services.
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Table 1: International Consensus Recommendations to Guide Endoscopy Recovery in the 
post pandemic phase of COVID-19
Statement 
Number
Statements Consensus 
after Round 
1
Statement modification Final 
Consensus
PRE-ENDOSCOPY
1 All patients coming 
for endoscopy should 
have a clinical history 
taken to diagnose 
active COVID-19 
disease or contact 
with any infected 
person in the last 2 
weeks
97.1% None 97.1%
2 The absence of 
clinical symptoms 
does not exclude 
SARS-CoV-2 infection 
as asymptomatic 
infections are not 
uncommon
94.1% None 94.1%
3 All patients 
undergoing 
endoscopy should be 
tested for SARS-CoV-
2 infection 24-72 
hours prior to 
endoscopy 
65.5% All patients undergoing 
endoscopic procedures 
should be tested for 
SARS-CoV-2 infection 
24-72 hours prior to
endoscopy in high
prevalence regions
82.4%
4 Patients who have 
tested negative for 
SARS-CoV-2 infection 
may still be infective
80.6% None 80.6%
5 The data on the 
accuracy of point of 
care tests to detect 
active infection is 
limited but 
promising. They 
should be used in a 
research or audit 
setting until more 
69% Early data on the 
accuracy of point of 
care tests for detection 
of active infection is 
promising and these 
tests could be used to 
aid with risk 
stratification of patients 
prior to endoscopy in 
high prevalence regions
91.1%
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data becomes 
available
6 All patients having 
endoscopic 
procedures lasting 
longer than 1 hour 
should be tested for 
SARS-CoV-2 infection 
51.7% In the absence of 
universal testing, all 
patients having 
therapeutic endoscopic 
procedures lasting 
longer than 1 hour 
should be tested for 
SARS-CoV-2 infection in 
high prevalence regions
85.3%
7 All health care 
professionals should 
be self reporting any 
new symptoms to a 
responsible health 
professional who is 
able to advise on 
further appropriate 
action 
100% None 100%
8 All healthcare 
professionals working 
in endoscopy should 
be tested for SARS-
CoV-2 infection on a 
cyclical basis 
58.6% All healthcare 
professionals working 
in endoscopy should be 
tested once for SARS-
CoV-2 infection, 
undergo daily symptom 
and temperature checks 
and in high prevalence 
regions consider 
retesting on a regular 
basis 
88.2%
9 All patients attending 
for endoscopic 
procedures should 
wear simple surgical 
masks at all times 
apart from the time 
when an endoscope 
has to be inserted 
into the oral cavity
97.1% None 97.1%
10 All health care 
professionals should 
be wearing surgical 
94.1% None 94.1%
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masks at all times in 
clinical areas within 
the endoscopy 
department
11 Elective endoscopy 
for suspected or 
confirmed COVID-19 
patients should be 
deferred until they 
are asymptomatic 
and have tested 
negative
94.1% None 94.1%
12 Self isolation of 
patients for 1 week 
prior to endoscopy is 
not necessary if they 
are undergoing 
testing for SARS-CoV-
2 infection prior to 
endoscopy
44.8% Patients should observe 
adequate social 
distancing for 1 week 
prior to endoscopy in 
high prevalence regions 
to minimise the risk of 
viral exposure to health 
care professionals in 
endoscopy departments
80.6%
13 Health care 
professionals should 
receive appropriate 
training in infection 
control practices and 
handling of personal 
protective equipment 
(PPE)
100% None 100%
DURING ENDOSCOPY
14 Gastroscopy is an 
aerosol generating 
procedure (AGP) and 
health care 
professionals should 
wear enhanced 
personal protective 
equipment 
(N95/FFP3 
respirators) in high 
prevalence regions
82.3% None 82.3%
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15 We recommend the 
use of enhanced 
personal protective 
equipment 
(N95/FFP3) 
respirators for all 
endoscopic 
procedures in the 
upper and lower 
gastrointestinal tract 
69% In high prevalence 
regions, the use of 
enhanced PPE 
(N95/FFP3 respirators) 
for both upper and 
lower gastrointestinal 
endoscopic procedures 
is recommended due to 
uncertainty surrounding 
the risk of infection 
during colonoscopy
88.2%
16 Standard PPE with a 
surgical mask is 
sufficient for low 
aerosol generating 
procedures such as 
colonoscopy 
37.9% In low prevalence 
regions, standard PPE 
(surgical mask) is 
sufficient for low 
aerosol generating 
procedures such as 
colonoscopy 
82.4%
17 In the absence of 
active testing all 
patients undergoing 
endoscopic 
procedures should be 
presumed to be 
potentially infective 
and health care 
professionals should 
wear enhanced PPE 
(N95/FFP3 
respirators)
85.3% None 85.3%
18 The “Donning” area 
(where PPE is worn) 
should be located 
outside of the 
endoscopy room and 
away from the 
“doffing” area (where 
PPE is removed)
94.0% None 94.0%
19 All patients in high 
prevalence regions 
should change into 
hospital gowns 
before entering the 
endoscopy suites
85.3% None 85.3%
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20 All patients with 
suspected or 
confirmed COVID-19 
infection should be 
endoscoped in 
negative pressure 
rooms. In the 
absence of a negative 
pressure room, 
endoscopy 
departments should 
have a designated 
room and /or specific 
slots for these 
patients
100% None 100%
POST-ENDOSCOPY
21 The “Doffing” area 
for removal of PPE 
could be 
appropriately 
positioned in one 
corner of the room
85.2% None 85.2%
22 The endoscopy 
procedure room 
should be deep 
cleaned after every 
procedure 
69% The endoscopy 
procedure room should 
be deep cleaned after 
every procedure in a 
suspected or confirmed 
case of COVID-19 
97.1%
23 Patients with 
suspected or 
confirmed COVID-19 
infection should be 
recovered in a 
designated area away 
from all the other 
non-COVID-19 
patients
97.1% None 97.1%
24 Staff in the recovery 
area (for non-COVID-
19 patients) should 
wear standard PPE 
with surgical masks
72.4% In high prevalence 
regions, health care 
professionals in the 
endoscopy recovery 
areas (for non COVID-19 
85.3%
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patients) should wear 
standard PPE with 
surgical masks
25 Strict adherence to 
endoscope 
disinfection policies 
are mandatory
100% None 100%
26 Adequate social 
distancing should be 
maintained 
throughout all areas 
of the endoscopy unit 
in high prevalence 
regions 
100% None 100%
27 All patients should be 
followed up by phone 
in 14 days to identify 
any symptoms 
suggestive of COVID-
19 
62% All patients should be 
followed up by phone in 
10-14 days to identify
any symptoms
suggestive of COVID-19
in high prevalence
regions
82.3%
REJECTED STATEMENTS
1 All units should aim 
to move towards 
single use 
(disposable) 
accessories
75.9% All units in high 
prevalence regions 
should aim to move 
towards single use 
(disposable) accessories 
such as biopsy forceps, 
snares, needles, biopsy 
valves etc. 
73.5%
2 Use of general 
anaesthesia with 
endotracheal 
intubation should be 
considered for all 
upper GI procedures 
taking longer than 30 
mins 
37.9% Use of general 
anaesthesia with 
endotracheal intubation 
should be considered 
for all upper GI 
procedures in high 
prevalence regions 
taking longer than 30 
mins 
50%
3 The endoscopy 
procedure room 
should be left empty 
51.7% The endoscopy 
procedure room in high 
prevalence regions 
67.7%
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for 20 to 30 minutes 
after the patient 
leaves the room to 
allow for all droplets 
to settle down before 
deep cleaning is 
performed
should be left empty for 
20 to 30 minutes after 
the patient leaves the 
room to allow for all 
droplets to settle down 
before deep cleaning is 
performed
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Table 2: A Comparison between this international consensus document and major 
national endoscopy guidance in the era of COVID-19
This guidance Joint GI 
society 
(USA) 
message on 
COVID-193
 ESGE2 BSG1 APDSE7 ASGE4 AGA/
DHPA56
1 Clinical 
screening for 
all patients 
pre-
endoscopy
Yes Yes Yes Yes Yes Yes
2 Recognition 
that patients 
with COVID-
19 can be 
asymptomatic
Yes Not 
specified
Yes Not 
specified
Yes Not 
specified
3 Testing of all 
patients prior 
to endoscopy 
(in high 
prevalence 
regions) 
Not 
specified
Not 
specified
Not 
specified
Can be 
considere
d
Testing 
advised 
depending 
on 
availability
Yes
4 Patients who 
have tested 
negative for 
SARS-CoV-2 
infection may 
still be 
infective
Not 
specified
Not 
specified
Not 
specified
Not 
specified
Yes Not 
specified
5 Point of care 
tests for 
detection of 
infection may 
be useful 
Not 
specified
Not 
specified
Not 
specified
Not 
specified
Not 
specified
Not 
specified
6 Testing prior 
to therapeutic 
endoscopy 
lasting >1 
hour (in high 
prevalence 
regions) 
Not 
specified
Not 
specified
Not 
specified
Not 
specified
Not 
specified
Not 
specified
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7 Self 
surveillance 
and reporting 
of new 
symptoms 
amongst all 
HCP in 
endoscopy
Not 
specified
Yes Not 
specified
Not 
specified
Not 
specified
Not 
specified
8 All health care 
professionals 
working in 
endoscopy 
should be 
tested once 
for SARS-CoV-
2 infection 
and have daily 
temperature/
symptom 
screening  & 
retesting in 
high 
prevalence
Not 
specified
Not 
specified
Not 
specified
Not 
specified
Daily staff 
screening 
(symptom
s/tempera
ture) 
recomme
nded
Daily staff 
screening 
(symptoms
/temperat
ure) 
recommen
ded
9 Use of surgical 
masks for all 
patients 
attending 
endoscopy 
Yes- face 
masks
Yes – face 
masks 
Face 
masks for 
patients 
who are 
shielding
Not 
specified
Yes 
(surgical 
face 
masks)
Yes
10 Use of surgical 
masks for all 
health care 
professional 
working in 
clinical areas 
of the 
endoscopy 
department
“All 
members of 
the 
endoscopy 
team should 
wear a full 
set of PPE, 
predicated 
on resource 
availabilities
”
Yes 
(surgical 
face 
masks)
Not 
specified
Not 
specified
Yes 
(surgical 
face 
masks)
Yes
11 Deferment of 
elective 
endoscopy for 
suspected or 
confirmed 
COVID-19 
patients 
Yes Yes Yes Yes Yes Yes
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12 Patients 
should 
observe 
adequate 
social 
distancing for 
1 week prior 
to endoscopy 
(in high 
prevalence 
regions)  
Not 
specified
Not 
specified
Not 
specified
Not 
specified
Not 
specified
Not 
specified
13 Training of 
health care 
professionals 
in using PPE 
Yes Yes Not 
specified
Yes Yes Not 
specified
14 Health care 
professionals 
to wear 
N95/FFP3 
respirators for 
all 
gastroscopies 
in high 
prevalence 
regions
Yes (for 
patients 
with COVID-
19 and 
those at 
high risk of 
exposure)
Yes Yes PPE 
according 
to risk 
stratificati
on 
(Enhanced 
PPE for 
suspected 
or 
confirmed 
COVID-19)
Yes If test is 
negative, 
standard 
surgical 
mask for 
all 
procedures
15 In high 
prevalence 
regions, the 
use of 
enhanced PPE 
(N95/FFP3 
respirators) 
for both 
upper and 
lower 
gastrointestin
al endoscopic 
procedures 
Yes (see 
above)
Yes (see 
above)
PPE choice 
based on 
likelihood 
of COVID-
19 
infection
As per 
Public 
Health 
England 
guidance
(constantl
y 
changing)
As above Yes If test is 
negative, 
standard 
surgical 
mask for 
all 
procedures
16 In low 
prevalence 
regions, 
standard PPE 
Enhanced 
PPE for all GI 
procedures
PPE choice 
based on 
likelihood 
of COVID-
Standard 
PPE for 
lower GI 
procedur
PPE 
according 
to risk 
stratificati
N95 
respirator
s for all 
endoscopi
If test is 
negative, 
standard 
surgical 
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(surgical 
mask) is 
sufficient for 
colonoscopy 
19 
infection
es if 
patient 
has tested 
negative 
for 
COVID-19
on/likeliho
od of 
COVID-19
c 
procedure
s
mask for 
all 
procedures
(no 
distinction 
between 
OGD or 
colonosco
py)
17 In the absence 
of active 
testing all 
patients 
should be 
presumed to 
be infective 
and health 
care 
professionals 
should wear 
enhanced PPE 
Yes Yes Yes Yes Yes Yes
18 The 
“Donning” 
area should 
be located 
outside of the 
endoscopy 
room and 
away from the 
“doffing” area
Not 
specified
Not 
specified
Not 
specified
Not 
specified
Not 
specified
Not 
specified
19 All patients in 
high 
prevalence 
regions should 
change into 
hospital 
gowns before 
entering the 
endoscopy 
suites
Not 
specified
Not 
specified
Not 
specified
Not 
specified
Not 
specified
Not 
specified
20 Use of 
negative 
pressure 
rooms (or 
Yes (for 
suspected or 
confirmed 
COVID-19)
Yes (for 
suspected 
or 
Negative 
pressure 
not 
specified
Yes (for 
suspected 
or 
Not 
specified
(“Rooms 
lacking 
Not 
specified
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
designated 
rooms/specifi
c procedure 
slots) for 
COVID-19 
patients 
confirmed 
COVID-19)
confirmed 
COVID-19)
negative 
pressure 
benefit 
from 
additional 
aeration 
time”)
21  Location of 
“Doffing” area 
Not 
specified
Not 
specified
Not 
specified
Not 
specified
Not 
specified
Not 
specified
22 Deep cleaning 
of procedure 
room after 
every 
procedure 
Yes Yes Yes Yes Yes Yes
23 Separate 
recovery area 
required for 
COVID-19 
patients 
Not 
specified
Yes Not 
specified
Not 
specified
Not 
specified
Not 
specified
24 Health care 
professionals 
in non-COVID-
19 recovery 
areas should 
wear standard 
PPE with 
surgical masks
Not 
specified
Not 
specified
Not 
specified
Yes Surgical 
mask, 
gloves 
required 
in post 
operative 
areas
(N-95 
depending 
on 
availability
)
Yes
25 Strict 
adherence to 
endoscope 
disinfection 
policies 
Yes Yes Yes Yes Yes Yes
26 Adequate 
social 
distancing 
measures in 
endoscopy 
Yes Yes Yes 
(“linear 
patient 
flow”)
Not 
specified
Yes Yes
27 Follow up of 
patients 10-14 
days post 
procedure 
Not 
specified
At 7 and 
14 days 
after 
endoscopy 
Not 
specified
Not 
specified
Yes 
(1-2 weeks 
post 
procedure
)
Not 
specified
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
for all 
patients
ESGE: European Society of Gastrointestinal Endoscopy; BSG: British Society of 
Gastroenterology; APDSE: Asia Pacific Society for Digestive Endoscopy; ASGE: American 
Society of Gastrointestinal Endoscopy; AGA: American Gastroenterological Association; 
DHPA: Digestive Health Physicians Association; PPE: Personal Protective Equipment
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